{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:34:38Z","timestamp":1791891278743,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7019","license":[{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:00:00Z","timestamp":1103155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2004,12,16]]},"DOI":"10.1038\/nature03087","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T07:50:30Z","timestamp":1103183430000},"page":"901-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Public health vaccination policies for containing an anthrax outbreak"],"prefix":"10.1038","volume":"432","author":[{"given":"Ron","family":"Brookmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnature03087_CR1","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","volume":"281","author":"TV Inglesby","year":"1999","unstructured":"Inglesby, T. V. et al. Anthrax as a biological weapon: medical and public health management. J. Am. Med. Assoc. 281, 1735\u20131745 (1999)","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature03087_CR2","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","volume":"287","author":"TV Inglesby","year":"2002","unstructured":"Inglesby, T. V. et al. Anthrax as a biological weapon. Updated recommendations for management. J. Am. Med. Assoc. 287, 2236\u20132252 (2002)","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature03087_CR3","first-page":"1024","volume":"51","author":"Centers for Disease Control","year":"2002","unstructured":"Centers for Disease Control. Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. Morb. Mortal. Wkly Rep. 51, 1024\u20131026 (2002)","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"BFnature03087_CR4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","volume":"17","author":"JA Jernigan","year":"2001","unstructured":"Jernigan, J. A. et al. Bioterrorism-related inhalation anthrax: The first 10 cases reported in the United States. Emerg. Infect. Dis. 17, 933\u2013944 (2001)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature03087_CR5","doi-asserted-by":"crossref","unstructured":"Joellenbeck, L., Zwanziger, L., Durch, J. & Strom, B. (eds) The Anthrax Vaccine: Is it Safe? Does it Work? (National Academy Press, Washington DC, 2002)","DOI":"10.21236\/ADA403352"},{"key":"BFnature03087_CR6","unstructured":"National Institute of Allergy and Infectious Diseases. National Institute of Allergy and Infectious Diseases biodefense research agenda for CDC category A agents. \u3008http:\/\/www.niaid.nih.gov\/publications\/bioterrorism.htm\u3009 (2002)."},{"key":"BFnature03087_CR7","first-page":"1008","volume":"50","author":"Centers for Disease Control","year":"2001","unstructured":"Centers for Disease Control. Update: investigation of bioterrorism-related anthrax. Morb. Mortal. Wkly Rep. 50, 1008\u20131010 (2001)","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"BFnature03087_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3201\/eid0810.020349","volume":"8","author":"CW Shepard","year":"2002","unstructured":"Shepard, C. W. et al. Antimicrobial post-exposure prophylaxis for anthrax: Adverse events and adherence. Emerg. Infect. Dis. 8, 1124\u20131132 (2002)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature03087_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.1068474","volume":"295","author":"R Brookmeyer","year":"2002","unstructured":"Brookmeyer, R. & Blades, N. Prevention of inhalational anthrax in the U.S. outbreak. Science 295, 1861 (2002)","journal-title":"Science"},{"key":"BFnature03087_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.7973702","volume":"266","author":"M Meselson","year":"1994","unstructured":"Meselson, M. et al. The Sverdlovsk anthrax outbreak of 1979. Science 266, 1202\u20131208 (1994)","journal-title":"Science"},{"key":"BFnature03087_CR11","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1073\/pnas.0636861100","volume":"100","author":"LM Wein","year":"2003","unstructured":"Wein, L. M., Craft, D. L. & Kaplan, E. H. Emergency response to an anthrax outbreak. Proc. Natl Acad. Sci. USA 100, 4346\u20134351 (2003)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature03087_CR12","volume-title":"Chemical and Biological Terrorism","author":"Committee on Research and Development Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents","year":"1999","unstructured":"Committee on Research and Development Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents. Chemical and Biological Terrorism (National Academy Press, Washington DC, 1999)"},{"key":"BFnature03087_CR13","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1073\/pnas.162282799","volume":"99","author":"EH Kaplan","year":"2002","unstructured":"Kaplan, E. H., Craft, D. L. & Wein, L. M. Emergency response to a smallpox attack: the case for mass vaccination. Proc. Natl Acad. Sci. USA 99, 10935\u201310940 (2002)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature03087_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMsa025075","volume":"348","author":"S Bozette","year":"2003","unstructured":"Bozette, S. et al. A model for a smallpox-vaccination policy. N. Engl. J. Med. 348, 416\u2013425 (2003)","journal-title":"N. Engl. J. Med."},{"key":"BFnature03087_CR15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.1074674","volume":"298","author":"ME Halloran","year":"2002","unstructured":"Halloran, M. E., Longini, I. M. Jr, Nizam, A. & Yang, Y. Containing bioterrorist smallpox. Science 298, 1428\u20131432 (2002)","journal-title":"Science"},{"key":"BFnature03087_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nature02007","volume":"425","author":"NM Ferguson","year":"2003","unstructured":"Ferguson, N. M. et al. Planning for smallpox outbreak. Nature 425, 681\u2013685 (2003)","journal-title":"Nature"},{"key":"BFnature03087_CR17","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1073\/pnas.0307506101","volume":"101","author":"C Fraser","year":"2004","unstructured":"Fraser, C., Riley, S., Anderson, R. M. & Ferguson, N. M. Factors that make an infectious disease outbreak controllable. Proc. Natl Acad. Sci. USA 101, 6146\u20136151 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature03087_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3201\/eid0302.970201","volume":"3","author":"A Kaufmann","year":"1997","unstructured":"Kaufmann, A., Meltzer, M. & Schmid, G. The economic impact of a bioterrorist attack: Are prevention and post attack intervention programs justifiable? Emerg. Infect. Dis. 3, 83\u201394 (1997)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature03087_CR19","unstructured":"Centers for Disease Control and Prevention. Mass antibiotic dispensing: A primer. \u3008http:\/\/www.phppo.cdc.gov\/phtn\/antibiotic\/default.asp\u3009 (June 2004)."},{"key":"BFnature03087_CR20","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1073\/pnas.1631983100","volume":"100","author":"R Brookmeyer","year":"2003","unstructured":"Brookmeyer, R., Johnson, E. & Bollinger, R. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc. Natl Acad. Sci. USA 100, 10129\u201310132 (2003)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature03087_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.1980.tb18910.x","volume":"353","author":"PS Brachman","year":"1980","unstructured":"Brachman, P. S. Inhalation anthrax. Ann. NY Acad. Sci. 353, 83\u201393 (1980)","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnature03087_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/path.1700730219","volume":"73","author":"JM Ross","year":"1957","unstructured":"Ross, J. M. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73, 484\u2013494 (1957)","journal-title":"J. Pathol. Bacteriol."},{"key":"BFnature03087_CR23","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","volume":"167","author":"AM Friedlander","year":"1993","unstructured":"Friedlander, A. M. et al. Post-exposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167, 1239\u20131242 (1993)","journal-title":"J. Infect. Dis."},{"key":"BFnature03087_CR24","first-page":"335","volume":"20","author":"AM Friedlander","year":"2000","unstructured":"Friedlander, A. M. Anthrax: clinical features, pathogenesis and potential biological warfare threat. Curr. Clin. Top. Infect. Dis. 20, 335\u2013349 (2000)","journal-title":"Curr. Clin. Top. Infect. Dis."},{"key":"BFnature03087_CR25","first-page":"51","volume":"5","author":"TJ Cieslak","year":"1999","unstructured":"Cieslak, T. J. & Edward, M. E. Clinical and epidemiological principles of anthrax. Infect. Dis. 5, 51\u201355 (1999)","journal-title":"Infect. Dis."},{"key":"BFnature03087_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1017\/S0022172400044272","volume":"54","author":"DW Henderson","year":"1956","unstructured":"Henderson, D. W., Peakcock, S. & Belton, F. C. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. (Lond.) 54, 28\u201335 (1956)","journal-title":"J. Hyg. (Lond.)"},{"key":"BFnature03087_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/0272-4332.00028","volume":"22","author":"CN Haas","year":"2002","unstructured":"Haas, C. N. On the risk of mortality to primates exposed to anthrax spores. Risk Anal. 22, 189\u2013193 (2002)","journal-title":"Risk Anal."},{"key":"BFnature03087_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0950268800068497","volume":"113","author":"A Watson","year":"1994","unstructured":"Watson, A. & Keir, D. Information on which to base assessments of risk from environmental contaminated with anthrax spores. Epidemiol. Infect. 113, 479\u2013490 (1994)","journal-title":"Epidemiol. Infect."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature03087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature03087","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature03087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:09:31Z","timestamp":1744358971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature03087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,16]]},"references-count":28,"journal-issue":{"issue":"7019","published-print":{"date-parts":[[2004,12,16]]}},"alternative-id":["BFnature03087"],"URL":"https:\/\/doi.org\/10.1038\/nature03087","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,16]]},"assertion":[{"value":"14 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}